Retirement Systems of Alabama increased its position in Mylan (NASDAQ:MYL) by 0.8% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 538,814 shares of the company’s stock after buying an additional 4,494 shares during the period. Retirement Systems of Alabama owned 0.10% of Mylan worth $21,008,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the company. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Mylan by 0.4% in the fourth quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 26,380 shares of the company’s stock worth $1,006,000 after buying an additional 107 shares during the period. Kernodle & Katon Asset Management Group LLC increased its stake in Mylan by 4.7% in the third quarter. Kernodle & Katon Asset Management Group LLC now owns 2,884 shares of the company’s stock worth $110,000 after buying an additional 129 shares during the period. Cim Investment Mangement Inc. increased its stake in Mylan by 1.2% in the fourth quarter. Cim Investment Mangement Inc. now owns 11,960 shares of the company’s stock worth $456,000 after buying an additional 143 shares during the period. New England Research & Management Inc. increased its stake in Mylan by 3.0% in the first quarter. New England Research & Management Inc. now owns 8,450 shares of the company’s stock worth $329,000 after buying an additional 250 shares during the period. Finally, Kanawha Capital Management LLC increased its stake in Mylan by 0.9% in the third quarter. Kanawha Capital Management LLC now owns 29,285 shares of the company’s stock worth $1,116,000 after buying an additional 260 shares during the period. Institutional investors and hedge funds own 60.89% of the company’s stock.
Mylan (NASDAQ:MYL) traded down 0.67% on Friday, hitting $36.83. 3,863,997 shares of the company’s stock traded hands. Mylan has a 12 month low of $33.60 and a 12 month high of $50.40. The stock has a market cap of $19.72 billion, a P/E ratio of 40.03 and a beta of 1.14. The stock has a 50 day moving average price of $40.82 and a 200-day moving average price of $38.68.
Mylan (NASDAQ:MYL) last released its earnings results on Wednesday, March 1st. The company reported $1.57 earnings per share for the quarter, topping analysts’ consensus estimates of $1.42 by $0.15. Mylan had a return on equity of 22.04% and a net margin of 2.50%. The business had revenue of $3.27 billion for the quarter, compared to analyst estimates of $3.18 billion. During the same quarter last year, the firm posted $1.22 earnings per share. Equities analysts predict that Mylan will post $5.29 earnings per share for the current fiscal year.
WARNING: This story was originally posted by Ticker Report and is the property of of Ticker Report. If you are viewing this story on another domain, it was illegally stolen and republished in violation of United States and international trademark & copyright law. The correct version of this story can be viewed at https://www.tickerreport.com/banking-finance/2485840/mylan-myl-shares-bought-by-retirement-systems-of-alabama.html.
A number of brokerages have weighed in on MYL. Citigroup Inc lowered shares of Mylan from a “buy” rating to a “neutral” rating and cut their target price for the stock from $59.00 to $44.00 in a research report on Thursday, January 5th. They noted that the move was a valuation call. Guggenheim reiterated a “neutral” rating on shares of Mylan in a research report on Friday, March 3rd. Zacks Investment Research upgraded shares of Mylan from a “sell” rating to a “hold” rating in a research report on Monday, February 27th. Vetr lowered shares of Mylan from a “strong-buy” rating to a “buy” rating and set a $44.68 price objective for the company. in a research report on Tuesday, February 14th. Finally, Stifel Nicolaus restated a “positive” rating on shares of Mylan in a research report on Friday, December 30th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, nine have given a buy rating and two have given a strong buy rating to the stock. Mylan presently has a consensus rating of “Buy” and an average target price of $51.96.
In other Mylan news, major shareholder Laboratories Abbott sold 44,000,000 shares of the stock in a transaction on Thursday, March 23rd. The stock was sold at an average price of $41.60, for a total value of $1,830,400,000.00. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.71% of the company’s stock.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.